Partial
Mostly Aligned
Patient Risk:
Low
Summary
Two of the three claims are supported by the labeling; one claim regarding the brand-name relationship is not explicitly supported by the provided label text.
Category Scores
Accurate Statements
Enoxaparin is also written as enoxaparin sodium.
11
Enoxaparin is an anticoagulant.
12.1
Unsupported Statements
Lovenox is the brand name for enoxaparin.
Label section 11 describes Lovenox as a sterile solution containing enoxaparin sodium but does not explicitly state that Lovenox is the brand name for enoxaparin.
Contradictions
Important Omissions
Explicit statement in the label that Lovenox is the brand name for enoxaparin.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Evaluation limited to labeling statements about composition and mechanism; no safety data evaluated.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Brand-name claim not explicitly supported by the label text.
Suggested Improvement
Clarify in the evaluation whether the label explicitly identifies Lovenox as the brand name for enoxaparin; if asserting brand-name relationships, ensure explicit labeling language is present.